These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10831488)

  • 61. Serotonin(2A) receptors are reduced in the planum temporale from subjects with schizophrenia.
    Pralong D; Tomaskovic-Crook E; Opeskin K; Copolov D; Dean B
    Schizophr Res; 2000 Jul; 44(1):35-45. PubMed ID: 10867310
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Opposite alterations of 5-HT
    Diez-Alarcia R; Muguruza C; Rivero G; García-Bea A; Gómez-Vallejo V; Callado LF; Llop J; Martín A; Meana JJ
    Transl Psychiatry; 2021 May; 11(1):302. PubMed ID: 34016955
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 5HT2 receptors in cerebral cortex of migraineurs studied using PET and 18F-fluorosetoperone.
    Chabriat H; Tehindrazanarivelo A; Vera P; Samson Y; Pappata S; Boullais N; Bousser MG
    Cephalalgia; 1995 Apr; 15(2):104-8; discussion 77. PubMed ID: 7641243
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Distribution of 5HT2A receptors in the human brain: comparison of data in vivo and post mortem.
    Forutan F; Estalji S; Beu M; Nikolaus S; Hamacher K; Coenen HH; Vosberg H; Müller-Gärtner HW; Larisch R
    Nuklearmedizin; 2002; 41(4):197-201. PubMed ID: 12224404
    [TBL] [Abstract][Full Text] [Related]  

  • 65. 18F-fallypride binding potential in patients with schizophrenia compared to healthy controls.
    Lehrer DS; Christian BT; Kirbas C; Chiang M; Sidhu S; Short H; Wang B; Shi B; Chu KW; Merrill B; Buchsbaum MS
    Schizophr Res; 2010 Sep; 122(1-3):43-52. PubMed ID: 20655709
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Alterations in the serotonin system in schizophrenia: a systematic review and meta-analysis of postmortem and molecular imaging studies.
    Selvaraj S; Arnone D; Cappai A; Howes O
    Neurosci Biobehav Rev; 2014 Sep; 45():233-45. PubMed ID: 24971825
    [TBL] [Abstract][Full Text] [Related]  

  • 67. 5-HT2 receptor distribution shown by [18F] setoperone PET in high-functioning autistic adults.
    Beversdorf DQ; Nordgren RE; Bonab AA; Fischman AJ; Weise SB; Dougherty DD; Felopulos GJ; Zhou FC; Bauman ML
    J Neuropsychiatry Clin Neurosci; 2012; 24(2):191-7. PubMed ID: 22772667
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Disturbance of serotonin 5HT2 receptors in remitted patients suffering from hereditary depressive disorder.
    Larisch R; Klimke A; Mayoral F; Hamacher K; Herzog HR; Vosberg H; Tosch M; Gaebel W; Rivas F; Coenen HH; Müller-Gärtner HW
    Nuklearmedizin; 2001 Aug; 40(4):129-34. PubMed ID: 11556203
    [TBL] [Abstract][Full Text] [Related]  

  • 69. EMD 281014, a specific and potent 5HT2 antagonist in humans: a dose-finding PET study.
    Mamo D; Sedman E; Tillner J; Sellers EM; Romach MK; Kapur S
    Psychopharmacology (Berl); 2004 Sep; 175(3):382-8. PubMed ID: 15007535
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction.
    Meltzer CC; Smith G; Price JC; Reynolds CF; Mathis CA; Greer P; Lopresti B; Mintun MA; Pollock BG; Ben-Eliezer D; Cantwell MN; Kaye W; DeKosky ST
    Brain Res; 1998 Nov; 813(1):167-71. PubMed ID: 9824691
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats.
    Onwordi EC; Halff EF; Whitehurst T; Mansur A; Cotel MC; Wells L; Creeney H; Bonsall D; Rogdaki M; Shatalina E; Reis Marques T; Rabiner EA; Gunn RN; Natesan S; Vernon AC; Howes OD
    Nat Commun; 2020 Jan; 11(1):246. PubMed ID: 31937764
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Atypical antipsychotics, schizophrenia and cortical 5-HT2A receptors.
    Collier DA
    Mol Psychiatry; 1998 May; 3(3):211. PubMed ID: 9672893
    [No Abstract]   [Full Text] [Related]  

  • 73. Decreased frontal cortical serotonin2A receptors in schizophrenia.
    Dean B; Hayes W
    Schizophr Res; 1996 Sep; 21(3):133-9. PubMed ID: 8885041
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of serotonin antagonism in schizophrenia: a pilot study with setoperone.
    Ceulemans DL; Gelders YG; Hoppenbrouwers ML; Reyntjens AJ; Janssen PA
    Psychopharmacology (Berl); 1985; 85(3):329-32. PubMed ID: 3923519
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The cortical serotonin2A receptor and the pathology of schizophrenia: a likely accomplice.
    Dean B
    J Neurochem; 2003 Apr; 85(1):1-13. PubMed ID: 12641722
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Epigenetic mechanisms and the serotonin 2A receptor in schizophrenia.
    Dean B
    Schizophr Res; 2013 Apr; 145(1-3):128-9. PubMed ID: 23403414
    [No Abstract]   [Full Text] [Related]  

  • 77. Hypofrontality in schizophrenia as assessed by PET.
    Buchsbaum MS; Wu JC
    Am J Psychiatry; 1987 Jan; 144(1):122-3. PubMed ID: 2879481
    [No Abstract]   [Full Text] [Related]  

  • 78. Serotonin2A receptors in schizophrenia: relation to suicide.
    Meltzer HY
    Arch Gen Psychiatry; 1994 Dec; 51(12):1003-4. PubMed ID: 7979879
    [No Abstract]   [Full Text] [Related]  

  • 79. Acute sleep deprivation upregulates serotonin 2A receptors in the frontal cortex of mice via the immediate early gene Egr3.
    Zhao X; Ozols AB; Meyers KT; Campbell J; McBride A; Marballi KK; Maple AM; Raskin C; Mishra A; Noss SM; Beck KL; Khoshaba R; Bhaskara A; Godbole MN; Lish JR; Kang P; Hu C; Palner M; Overgaard A; Knudsen GM; Gallitano AL
    Mol Psychiatry; 2022 Mar; 27(3):1599-1610. PubMed ID: 35001075
    [TBL] [Abstract][Full Text] [Related]  

  • 80. DNA Methylation and Schizophrenia: Current Literature and Future Perspective.
    Magwai T; Shangase KB; Oginga FO; Chiliza B; Mpofana T; Xulu KR
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.